Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Islets Langerhans”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03097185
What this trial is testing

Analysis of Graft Function Following Autologous Islet Transplantation

Who this might be right for
Chronic Pancreatitis
Baylor Research Institute 100
Testing effectiveness (Phase 2)UnknownNCT02455596
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 20
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT01024387
What this trial is testing

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 60
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03544242
What this trial is testing

Nitrite Infusion in Islet Cell Transplantation

Who this might be right for
Diabetes
University of Alabama at Birmingham 4
Not applicableUnknownNCT05523778
What this trial is testing

A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct

Who this might be right for
Insulinoma
Peking Union Medical College Hospital 78
Not applicableUnknownNCT02624154
What this trial is testing

Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Who this might be right for
Pancreatic Neuroendocrine Tumor
First Affiliated Hospital, Sun Yat-Sen University 2
Not applicableUnknownNCT01563133
What this trial is testing

Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas

Who this might be right for
Pancreatic CystPancreatic NeoplasmsPancreatic Adenoma+4 more
Mauna Kea Technologies 330
Testing effectiveness (Phase 2)Ended earlyNCT03736720
What this trial is testing

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Who this might be right for
Locally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine Carcinoma+5 more
Roswell Park Cancer Institute 11
Not applicableUnknownNCT02940184
What this trial is testing

GLP-1 Signaling in Truncally Vagotomized Subjects

Who this might be right for
Physiology
University of Copenhagen 24
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT00363051
What this trial is testing

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Who this might be right for
Islet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more
Novartis Pharmaceuticals 160
Not applicableLooking for participantsNCT07585032
What this trial is testing

Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

Who this might be right for
Insulinoma; Pancreas
Sahlgrenska University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02038738
What this trial is testing

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Who this might be right for
NeuroendocrineNeuroendocrine TumorNeuroendocrine Cancer+5 more
Ochsner Health System 250
Early research (Phase 1)Study completedNCT00530686
What this trial is testing

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

Who this might be right for
Islet Cell TransplantationType 1 Diabetes
Baylor Research Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT01374451
What this trial is testing

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Who this might be right for
Islet Cell Tumor
Novartis Pharmaceuticals 160
Early research (Phase 1)UnknownNCT02402439
What this trial is testing

Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol

Who this might be right for
Diabetes Mellitus, Type 1
Andrew Posselt 3
Testing effectiveness (Phase 2)Ended earlyNCT00639600
What this trial is testing

Transplantation of Pancreatic Islets in Patients With Type 1 Diabetes Mellitus and Functional Kidney Graft

Who this might be right for
Type 1 Diabetes Mellitus
University Hospital, Grenoble 21
Testing effectiveness (Phase 2)UnknownNCT03204019
What this trial is testing

Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Pancreatic Neuroendocrine Tumor
Chinese Academy of Medical Sciences 60
Next Page
355